EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prevalence of Sarcopenia and Its Defining Components in Non-alcoholic Fatty Liver Disease Varies According to the Method of Assessment and Adjustment: Findings from the UK Biobank

Christine L Freer iD, Elena S George, Sze-Yen Tan, Gavin Abbott, David Scott, Robin M Daly

Calcified Tissue International · 2024

DOI: 10.1007/s00223-024-01212-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Calcified Tissue International, 2024. Verfasst von Christine L Freer und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Physical Activity and Nutrition, School of Exercise and Nutrition Sciences, Deakin University, Geelong, VIC, Australia. cfree@deakin.ed…. Hauptthemen laut MEDLINE: Sarcopenia, Non-alcoholic Fatty Liver Disease, Absorptiometry, Photon. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deakin University, National Health and Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sarcopenia may increase non-alcoholic fatty liver disease (NAFLD) risk, but prevalence likely varies with different diagnostic criteria. This study examined the prevalence of sarcopenia and its defining components in adults with and without NAFLD and whether it varied by the method of muscle mass assessment [bioelectrical impedance (BIA) versus dual-energy X-ray absorptiometry (DXA)] and adjustment (height 2 versus BMI). Adults ( n = 7266) in the UK Biobank study (45–79 years) with and without NAFLD diagnosed by MRI, were included. Sarcopenia was defined by the 2018 European Working Group on Sarcopenia in Older People definition, with low appendicular skeletal muscle mass (ASM) assessed by BIA and DXA and adjusted for height 2 or BMI. Overall, 21% of participants had NAFLD and the sex-specific prevalence of low muscle strength (3.6–7.2%) and sarcopenia (0.1–1.4%) did not differ by NAFLD status. However, NAFLD was associated with 74% (males) and 370% (females) higher prevalence of low ASM when adjusted for BMI but an 82% (males) to 89% (females) lower prevalence when adjusted for height 2 (all P < 0.05). The prevalence of impaired physical function was 40% (males, P = 0.08) to 123% (females, P < 0.001) higher in NAFLD. In middle-aged and older adults, NAFLD was not associated with a higher prevalence of low muscle strength or sarcopenia but was associated with an increased risk of impaired physical function and low muscle mass when adjusted for BMI. These findings support the use of adiposity-based adjustments when assessing low muscle mass and the assessment of physical function in NAFLD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcopeniaNon-alcoholic Fatty Liver DiseaseAbsorptiometry, PhotonHumansMaleFemaleMiddle AgedUnited KingdomAgedPrevalenceBiological Specimen BanksMuscle, SkeletalMuscle StrengthElectric ImpedanceBody Mass IndexUK Biobank

Stichwörter der Autor:innen

Muscle massMuscle strengthNon-alcoholic fatty liver diseasePhysical functionSarcopeniaUK Biobank

Autor:innen und Institutionen

  • Institute for Physical Activity and Nutrition, School of Exercise and Nutrition Sciences, Deakin University, Geelong, VIC, Australia. cfree@deakin.edu.au.
  • Institute for Physical Activity and Nutrition, School of Exercise and Nutrition Sciences, Deakin University, Geelong, VIC, Australia.
  • School of Clinical Sciences at Monash Health, Monash University, Clayton, Australia.

ORCID-Profile: Christine L Freer

Förderung

  • Deakin University
  • National Health and Medical Research Council

Zitieren

APA

Freer, C. L., George, E. S., Tan, S. Y., Abbott, G., Scott, D., & Daly, R. M. (2024). Prevalence of Sarcopenia and Its Defining Components in Non-alcoholic Fatty Liver Disease Varies According to the Method of Assessment and Adjustment: Findings from the UK Biobank. Calcified Tissue International. https://doi.org/10.1007/s00223-024-01212-5

Vancouver

Freer CL, George ES, Tan SY, Abbott G, Scott D, Daly RM. Prevalence of Sarcopenia and Its Defining Components in Non-alcoholic Fatty Liver Disease Varies According to the Method of Assessment and Adjustment: Findings from the UK Biobank. Calcified Tissue International. 2024. doi:10.1007/s00223-024-01212-5

BibTeX
@article{Freer2024,
  author = {Freer, Christine L and George, Elena S and Tan, Sze-Yen and Abbott, Gavin and Scott, David and Daly, Robin M},
  title = {Prevalence of Sarcopenia and Its Defining Components in Non-alcoholic Fatty Liver Disease Varies According to the Method of Assessment and Adjustment: Findings from the UK Biobank},
  journal = {Calcified Tissue International},
  year = {2024},
  doi = {10.1007/s00223-024-01212-5}
}
Kostenlos starten →